PubMed · 15746478
Apathy: why care?
Abstract
This review presents data showing that apathy is common across a number of disorders. Apathy is not only common, but is also associated with significant problems: reduced functional level, decreased response to treatment, poor illness outcome, caregiver distress, and chronicity. Preliminary evidence of treatment efficacy exists for dopaminergic drugs and for amphetamines. Strong evidence of efficacy exists for acetylcholinesterase inhibitors in Alzheimer's disease, and for atypical antipsychotics in schizophrenia. Frontal-subcortical system(s) dysfunction is implicated in the causation of apathy; apathy subtypes based on the various frontal-subcortical loops may thus exist. Further research involving diagnosis, pathophysiology, and treatment is suggested.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Robert van Reekum, Donald T Stuss, Laurie Ostrander. 2005. Apathy: why care?. https://doi.org/10.1176/jnp.17.1.7. https://pubmed.health/record/pubmed%3A15746478/apathy-why-care
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.